Literature DB >> 16454710

Role of viral splicing elements and cellular RNA binding proteins in regulation of HIV-1 alternative RNA splicing.

C Martin Stoltzfus1, Joshua M Madsen.   

Abstract

In HIV-1 infected cells, over 40 different mRNA species are produced by alternative splicing of the single HIV-1 primary RNA transcript. In addition, approximately half of the HIV-1 primary RNA transcripts are not spliced and are exported to the cytoplasm where they serve as mRNA and as genomic RNA. In this article, we will review current knowledge of the mechanisms by which the HIV-1 alternative splicing is regulated. Several negatively and positively-acting cis-acting elements have been detected within the viral genome that repress or facilitate viral RNA splicing by binding to cellular proteins. These include exonic splicing silencers (ESS) and an intronic splicing silencer (ISS) that are selectively bound either by members of the hnRNP A/B family (hnRNPs A1, A1(B), A2, and B1) or by hnRNP H. Exonic splicing enhancers (ESE) are also present within the HIV-1 genome and are selectively bound by members of the SR protein family. ESS and ISS repression mediated by hnRNP A/B proteins occurs at early steps of splicing, prior to formation of pre-spliceosome complexes. Current models propose that ESS elements promote cooperative binding of hnRNP A/B proteins to the exon and prevent efficient binding of essential cellular splicing factors to the 3' splice site. SR proteins bound to ESE elements that are juxtaposed or overlapping ESS elements may counteract this inhibition. We will review data indicating the importance of the HIV-1 splicing elements and their cognate binding proteins for efficient virus replication. Differences in cis-acting splicing elements between the group M (major) and group O (outlier) HIV-1 strains will also be discussed. Finally we will review evidence suggesting the possibility that there may be changes in regulation of HIV-1 alternative splicing in infected human T cells, human macrophages and rodent cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16454710     DOI: 10.2174/157016206775197655

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  78 in total

Review 1.  Transcriptional and posttranscriptional regulation of HIV-1 gene expression.

Authors:  Jonathan Karn; C Martin Stoltzfus
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

2.  Role of cellular RNA processing factors in human immunodeficiency virus type 1 mRNA metabolism, replication, and infectivity.

Authors:  Joseph A Jablonski; Massimo Caputi
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

3.  Depletion of hnRNP A2/B1 overrides the nuclear retention of the HIV-1 genomic RNA.

Authors:  Heather Gordon; Lara Ajamian; Fernando Valiente-Echeverrìa; Kathy Lévesque; William F Rigby; Andrew J Mouland
Journal:  RNA Biol       Date:  2013-09-30       Impact factor: 4.652

4.  Driving factors in amiloride recognition of HIV RNA targets.

Authors:  Neeraj N Patwardhan; Zhengguo Cai; Aline Umuhire Juru; Amanda E Hargrove
Journal:  Org Biomol Chem       Date:  2019-10-30       Impact factor: 3.876

Review 5.  Idiosyncrasies of hnRNP A1-RNA recognition: Can binding mode influence function.

Authors:  Jeffrey D Levengood; Blanton S Tolbert
Journal:  Semin Cell Dev Biol       Date:  2018-04-09       Impact factor: 7.727

Review 6.  Splicing regulation: from a parts list of regulatory elements to an integrated splicing code.

Authors:  Zefeng Wang; Christopher B Burge
Journal:  RNA       Date:  2008-03-27       Impact factor: 4.942

7.  Identification of a heterogeneous nuclear ribonucleoprotein-recognition region in the HIV Rev protein.

Authors:  Kamyar Hadian; Michelle Vincendeau; Nina Mäusbacher; Daniel Nagel; Stefanie M Hauck; Marius Ueffing; Abraham Loyter; Thomas Werner; Horst Wolff; Ruth Brack-Werner
Journal:  J Biol Chem       Date:  2009-10-05       Impact factor: 5.157

8.  Rev-ing up post-transcriptional HIV-1 RNA expression.

Authors:  Venkat S R K Yedavalli; Kuan-Teh Jeang
Journal:  RNA Biol       Date:  2011-03-01       Impact factor: 4.652

9.  Quantitative analysis of clinically relevant mutations occurring in lymphoid cells harboring gamma-retrovirus-encoded hsvtk suicide genes.

Authors:  X Wang; M Olszewska; V Capacio; J Stefanski; M Przybylowski; S Samakoglu; A H Chang; M Sadelain; I Rivière
Journal:  Gene Ther       Date:  2008-06-19       Impact factor: 5.250

10.  Dual TLR2 and TLR7 agonists as HIV latency-reversing agents.

Authors:  Amanda B Macedo; Camille L Novis; Caroline M De Assis; Eric S Sorensen; Paula Moszczynski; Szu-Han Huang; Yanqin Ren; Adam M Spivak; R Brad Jones; Vicente Planelles; Alberto Bosque
Journal:  JCI Insight       Date:  2018-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.